Somerset Pharma, LLC, a US-based pharmaceutical company specializing in sterile injectables and ophthalmic products, announces the introduction of calcium gluconate 100 mg/mL in two sizes, 50 mL and 100 mL. This product approval also received the FDA’s Competitive Generic Therapy (CGT) designation with 180-day exclusivity. Calcium gluconate is an essential medicine used in the treatment of acute symptomatic hypocalcemia in pediatric and adult patients.

• Somerset Pharma, LLC